Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

Caroline Benedicte Kjærulff Mathiesen

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

Caroline Benedicte Kjærulff Mathiesen

University of Copenhagen

Research output: Contribution to conference without a publisher/journal › Poster › Communication

Original language	English
Publication date	30 Jan 2018
Publication status	Published - 30 Jan 2018
Event	Keystone Symposia: Emerging Technologies in Vaccine Discovery and Development - Banff, Canada Duration: 28 Jan 2018 → 2 Feb 2018

Conference

Conference	Keystone Symposia
Location	Banff, Canada
Period	28/01/18 → 02/02/18

Cite this

@conference{fdc62dc4356042a2ab1166ef022ae942,

title = "Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity",

author = "Mathiesen, \{Caroline Benedicte Kj{\ae}rulff\}",

year = "2018",

month = jan,

day = "30",

language = "English",

note = "Keystone Symposia : Emerging Technologies in Vaccine Discovery and Development ; Conference date: 28-01-2018 Through 02-02-2018",

}